- Home
- PLMR vs LGND Comparison
PLMR vs LGND Comparison
Compare PLMR & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMR
- LGND
- Stock Information
- Founded
- PLMR 2013
- LGND 1987
- Country
- PLMR United States
- LGND United States
- Employees
- PLMR N/A
- LGND 68
- Industry
- PLMR Property-Casualty Insurers
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- PLMR Finance
- LGND Health Care
- Exchange
- PLMR Nasdaq
- LGND Nasdaq
- Market Cap
- PLMR 3.3B
- LGND 3.2B
- IPO Year
- PLMR 2019
- LGND 1992
- Fundamental
- Price
- PLMR $123.21
- LGND $166.75
- Analyst Decision
- PLMR Buy
- LGND Strong Buy
- Analyst Count
- PLMR 8
- LGND 8
- Target Price
- PLMR $156.43
- LGND $144.71
- AVG Volume (30 Days)
- PLMR 279.2K
- LGND 139.7K
- Earning Date
- PLMR 11-03-2025
- LGND 08-05-2025
- Dividend Yield
- PLMR N/A
- LGND N/A
- EPS Growth
- PLMR 49.38
- LGND N/A
- EPS
- PLMR 5.68
- LGND N/A
- Revenue
- PLMR $682,205,000.00
- LGND $181,488,000.00
- Revenue This Year
- PLMR $256.23
- LGND $18.41
- Revenue Next Year
- PLMR $18.70
- LGND $18.87
- P/E Ratio
- PLMR $21.67
- LGND N/A
- Revenue Growth
- PLMR 52.98
- LGND 53.40
- 52 Week Low
- PLMR $85.00
- LGND $81.74
- 52 Week High
- PLMR $175.85
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- PLMR 45.05
- LGND 75.21
- Support Level
- PLMR $120.25
- LGND $158.40
- Resistance Level
- PLMR $126.57
- LGND $161.89
- Average True Range (ATR)
- PLMR 3.26
- LGND 3.32
- MACD
- PLMR 0.95
- LGND 0.09
- Stochastic Oscillator
- PLMR 42.30
- LGND 86.29
About PLMR Palomar Holdings Inc. Common stock
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.